Genetic immunization with cationic lipids

Details Genetic immunization with cationic lipids Genetic immunization with cationic lipids

2005-05-10

2005-05-10

Nguyen, Dave T. (Department: 1632)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C435S320100, C435S455000, C435S458000, C514S04400A, C424S130100

Reexamination Certificate

active

06890554

ABSTRACT:
A method for immunization using genetic material is disclosed. Compositions for genetic immunization comprising cationic lipids and polynucleotides are also disclosed. Methods for using genetic immunization to produce polyclonal and monoclonal antibodies are also disclosed. A method for epitope mapping is also disclosed.

REFERENCES:
patent: 4224404 (1980-09-01), Viza et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5166320 (1992-11-01), Wu et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5283185 (1994-02-01), Epand et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5641662 (1997-06-01), Debs et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5691460 (1997-11-01), Duvic et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5726298 (1998-03-01), Hirai et al.
patent: 5756353 (1998-05-01), Debs
patent: 5780053 (1998-07-01), Ashley et al.
patent: 5827703 (1998-10-01), Debs et al.
patent: 5908635 (1999-06-01), Thierry
patent: 5908777 (1999-06-01), Lee et al.
patent: 6030626 (2000-02-01), Kolattukudy et al.
patent: 6103492 (2000-08-01), Yu
patent: 6110662 (2000-08-01), Foung et al.
patent: 6214804 (2001-04-01), Felgner
patent: 6228844 (2001-05-01), Wolff et al.
patent: 6251390 (2001-06-01), Harman
patent: 6387395 (2002-05-01), Eppstein et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 20020086849 (2002-07-01), Gebeyehu et al.
patent: 20030032615 (2003-02-01), Felgner et al.
patent: 20030186913 (2003-10-01), Wolff et al.
patent: 0 465 529 (1998-04-01), None
patent: 0 523 189 (1999-06-01), None
patent: 1 026 253 (2000-08-01), None
patent: 0 737 750 (2003-05-01), None
patent: WO8805077 (1988-07-01), None
patent: WO9001543 (1990-02-01), None
patent: WO 9011092 (1990-10-01), None
patent: WO 9115501 (1991-10-01), None
patent: WO 9116024 (1991-10-01), None
patent: WO9116024 (1991-10-01), None
patent: WO9117424 (1991-11-01), None
patent: WO 9117424 (1991-11-01), None
patent: WO 9303709 (1993-03-01), None
patent: WO 9405624 (1994-03-01), None
US 2002/0198163, , 12/2002, Felgner et al. (withdrawn)
Gao et al. (Biochim. Biophys. Res. Comm. 179:280-285, 1991).*
Crystal, Science, vol. 270, 404-410 (1995).*
Robert Whalen, Emerging Infections Diseases, vol. w, 3:168-175 (1996).*
Zephati et al., J. Controlled Release, 1996, 41:97-119.*
PL Felgner et al (1991) Nature 349:351-352.*
Ciccarone, V. et al., “Cationic Liposome-Mediated Transfection of Eukaryotic Cells: High Efficiency Nucleic Acid Delivery With Lipofectin, Lipofectace, And Lipofectamine Reagents,”FASEB J. 7:A1131 Abstract No. 454 (Apr. 1993).*
Rosenthal, A.F. et al., A Synthetic Inhibitor of Venom Lecithinase A,Journal of Biological Chemistry 235: 2202-2206 (Aug. 1960).
Tang, D. et al., Genetic immunization is a simple method for eliciting an immune response,Nature 356: 152-154 (Mar. 12, 1992).
Thompson, L. “A Shot in the Arm for Vaccine Problems”Washington Post,p. A03 (Jun. 7, 1993).
Behr, J. et al., Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA,Proceedings of the National Academy of Science 86: 6982-6986 (Sep. 1989).
Benoist, C. et al., In vivo sequence requirements of the SV40 early promoter region,Nature 290: 304-310 (Mar. 26, 1981).
Cohen, J., Naked DNA Points Way to Vaccines,Science 259: 1691-1692 (Mar. 19, 1993).
Düzgünes, N. et al., Fusion of Liposomes Containing a Novel Cationic Lipid, N-[2,3-(Dioleyloxy)propyl]-N,N,N-trimethylammonium: Induction by Multivalent Anions and Asymmetric Fusion with Acidic Phospholipid Vesicles,Biochemistry 28: 9179-9184 (1989).
Felgner, P.L. et al., Cationic Liposome-Mediated Transfection,Focus 11: 21-25 (Spring 1989).
Felgner, P.L. et al., Cationic liposome-mediated transfection,Nature 337: 387-388 (Jan. 26, 1989).
Felgner, P.L. et al., Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,Proceedings of the National Academy of Science 84: 7413-7417 (Nov. 1987).
Foecking, M.K. et al., Powerful and versatile enhancer-promoter unit for mammalian expression vectors,Gene 45: 101-105 (1986).
Gao, X. et al., A novel cationic liposome reagent for efficient transfection of mammalian cells,Biochem. Biophys. Res. Commun. 179: 280-285 (Aug. 30, 1991).
Gorman, C. et al., “High Efficiency Gene Transfer into Mammalian Cells” in Glover, D.M., ed.,DNA Cloning,vol. II, IRL Press, Washington, D.C. pp. 143-190 (1985).
Hazinski, T.A. et al., Localization and Induced Expression of Fusion Genes in the Rat Lung,Am. J. Respir. Cell Mol. Biol. 4: 206-209 (1991).
Holt, C.E. et al., Lipofection of cDNAs in the Embryonic Vertebrate Central Nervous System,Neuron 4: 203-214 (Feb. 1990).
Benvenisty et al. (1986), “Direct introduction of genes into rats and expression of the genes,” Proc. Natl. Acad. Sci. 83:9551-9555.
Cotten, M. and Wagner, E. (1993), “Non-viral approaches to gene therapy,” Curr. Opinion Biotechnol. 4:705-710.
Dubensky et al. (1984), “Direct transfection of viral and plasmid DNA into the liver or spleen of mice,” Proc. Natl. Acad. Sci. 81:7529-7533.
Felgner, P.L. and Rhodes, G. (1991), “Gene Therapeutics,” Nature 349:351-352.
Felgner, P.L. and Ringold, G.M. (1989), “Cationic Liposome-Mediated Transfection,” Nature 337:387-388.
Felgner et al. (1987), “Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,” Proc. Natl. Acad. Sci. 84:7413-7417.
Litzinger, D.C. and Huang, L. (1992), “Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications,” Biochim. Biophys. Acta 1113:201-227.
Loyter et al. (1982), “Mechanisms of DNA uptake by mammalian cells: Fate of exogeneously added DNA monitored by the use of fluorescent dyes,” Proc. Natl. Acad. Sci. 79:422-426.
Malone et al. (1989), “Cationic liposome-mediated RNA transfection,” Proc. Natl. Acad. Sci. 86:6077-6081.
Mannino, R. and Gould-Fogerite, S. (1988), “Liposome Mediated Gene Transfer,” BioTechniques 6(7):682-690.
Nabel, G.J. and Felgner, P.L. (1993), “Direct gene transfer for immunotherapy and immunization,” TIBTECH 11:211-215.
Nicolau et al. (1983), “In Vivo expression of rat insulin after intravenous administration of the lipsome-entrapped gene for rat insulin I,” Proc. Natl. Acad. Sci. 80:1068-1072.
Nicolau, C. et al. (1987), “Liposomes as Carriers for in Vivo Gene Transfer and Expression,” Methods Enzymol. 149:157-176.
Rhodes, G. et al. (1990), “Intramuscular injection of an expression vector containing the gene for HIV GP 120 induces antibodies to the GP 120 protein,” Sixth Intl. Conf. on Aids, San Francisco, (Jun. 20-21, 1990), vol. 2 Abstracts, Abstract 1048.
Selden et al. (1988), “Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice,” Proc. Natl. Acad. Sci. 85:8241-8245.
Wolff, J.A. et al. (1990), “Direct gene transfer into mouse muscle in vivo,” Science 247:1465-1468.
Wu, C.H. et al. (1989), “Targeting Genes: Delivery and Persistent Expression of a Foreign Gene Driven by Mammalian Regulatory Elements in Vivo,” J. Biol. Chem. 264(29):16985-16987.
Johnstone & Thorpe, “Production of antibodies,” in:Immunochemistry in Practice,published by Blackwell Scientific Publications (Oxford), pp. 30-47 (1987).
Neurath et al., “B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19

Affiliated with

Also associated with

Rating

Genetic immunization with cationic lipids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetic immunization with cationic lipids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic immunization with cationic lipids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3463702